Yuan Li
- Cancer Research top 0.5%
- MicroRNA in disease regulation 38
- Cancer-related molecular mechanisms research 38
- Cancer Genomics and Diagnostics 23
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations 112
- Lung Cancer Diagnosis and Treatment 77
- Oncology top 0.5%
- Lung Cancer Research Studies 48
- Cancer Immunotherapy and Biomarkers 22
- Microbiology top 1%
- Molecular Biology top 1%
- RNA modifications and cancer 37
- Co-authors
- Haiquan ChenYihua SunYunjian PanYang ZhangLei ShenHang LiHaichuan HuTing Ye
- Journals
- PLoS ONE (15 papers)Journal of Cancer Research and Clinical Oncology (14 papers)Scientific Reports (12 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Yuan Li
500 papers receiving 11.6k citations
Peers
Comparison fields: 5 of 178
- Cancer Research 2.8k
- Pulmonary and Respiratory Medicine 4.3k
- Oncology 3.1k
- Microbiology 83
- Molecular Biology 4.7k
Countries citing papers authored by Yuan Li
This map shows the geographic impact of Yuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuan Li more than expected).
Fields of papers citing papers by Yuan Li
This network shows the impact of papers produced by Yuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuan Li. The network helps show where Yuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 10 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 6 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 20 | |
| 12 | 2023 | 1 | |
| 13 | 2023 | 2 | |
| 14 | 2023 | 11 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 1 | |
| 17 | 2015 | 74 | |
| 18 | 2014 | 83 | |
| 19 | 2014 | 116 | |
| 20 | 2012 | 75 |
About Yuan Li
Yuan Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Microbiology, having authored 534 papers that have together received 11.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (112 papers), Lung Cancer Diagnosis and Treatment (77 papers), Lung Cancer Research Studies (48 papers), MicroRNA in disease regulation (38 papers), Cancer-related molecular mechanisms research (38 papers), RNA modifications and cancer (37 papers), Cancer Genomics and Diagnostics (23 papers) and Cancer Immunotherapy and Biomarkers (22 papers). The work is most often cited by research in Cancer Research (2.8k citations), Pulmonary and Respiratory Medicine (4.3k citations) and Oncology (3.1k citations). Yuan Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Haiquan Chen, Yihua Sun, Yunjian Pan, Yang Zhang, Lei Shen, Hang Li, Haichuan Hu, Ting Ye, Rui Wang and Xiaoyang Luo. Their work appears in journals such as PLoS ONE, Journal of Cancer Research and Clinical Oncology, Scientific Reports, Journal of Thoracic Oncology and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.